U.S. recognition follows last month's announcement that Servier made the top ten list ... the top companies across several categories in PatientView's 2024 Corporate Reputation of Pharma in ...

We asked you to nominate those who you considered to be a top innovator in pharma. We were delighted ... 100 academic labs across the world and 6 pharmaceutical companies, and shares all reagents ...

The rankings of the top pharmaceutical companies in the world in 2017 presented a mixed ... Looking at recent research by GlobalData on the biggest pharma firms as listed by market capitalisation ...

Pharmaceutical packaging has evolved from a simple protective shell into a sophisticated tool for safety, adherence, and anti ...

the companies often fail to fetch optimum valuations over many years. Nevertheless, in a world with a growing aged population, the pharma sector remains one that cannot be ignored by governments ...

Trump on Sunday announced an executive order to bring down prescription drug prices. "Most favored nation" pricing would allow Americans to pay the lowest price worldwide. Pharma stocks erased ...

Over the past ten years, Zydus had mostly maintained payouts in the range ... especially among long-term investors hunting for value in pharma stocks. The India-branded formulations segment remained ...

Additionally, Trump also states that drug prices may increase in other parts of the world to make them “fair” with American prices. Technically, pharma companies could simply increase prices in other ...

India's outbound investments jumped 75% to $29.2 billion in FY25, while foreign firms repatriated a significant $51 billion, resulting in negligible net FDI despite gross FDI growing 14% to $81 ...

With President Donald Trump encouraging national and global companies to set up their production units in the United States, multinational Carrier and Kraft Heinz have announced their financial ...

Given a list of 40 drugmakers, the respondents rated ViiV most highly in terms of corporate reputation, followed by Servier—last year’s No. 1—and Amgen. ViiV also took the top spot when the patient ...